Federal Alzheimer research funding

The U.S. House and Senate approved separate versions of a “Budget Resolution” (S Con Res 70/ H Con Res 312) – a document that provides guidance on how much Congress should spend on specific federal programs, including Alzheimer research.

The Senate “Budget Resolution” recommended a $3 billion increase for all medical research – an effort led by Senators Specter (Pa.) and Harkin (Iowa). Congress is now in the process of resolving the differences between the two versions of the “Budget Resolution”.

The Alzheimer’s Association is urging Congress to accept the Senate-recommended increase for research. The overall amount recommended for research will be an important factor when the Appropriations Committees begin consideration of their annual appropriations bills.

If Congress is unable to reach agreement on the “Budget Resolution” by May, the Appropriations Committees are expected to begin debating individual bills. At this time, we do not know when the bill that funds research will be debated but will let you know when further action is needed!

While initial Alzheimer funding decisions will be made this spring, final votes on the appropriations bills are not expected until after the November presidential election.

The Association's goal is for Congress to increase funding for Alzheimer research by $125 million over current funding ($644 million) to accelerate clinical trials on new treatments and prevention methods and to improve techniques for earlier diagnosis.

What can I do now?

Ask your friends and family to help multiply our numbers on Capitol Hill!

We need more voices joining advocates storming the U.S. Capitol during our Day on the Hill in Washington D.C. on May 14 during the annual Public Policy Forum.

HOW? Share the Virtual Visit url: http://www.alz.kintera.org/virtualvisit

Personal messages from advocates will be hand-delivered to Congress by advocates from your state. 

Questions?

Would you like to receive this monthly update in your inbox? Sign up today!